title: Supportive therapy of the sepsis syndrome.
abstract: Adequate volume loading may be the most important step in the treatment of patients with septic shock. Techniques allowing us to achieve and tightly control volume loading and regional perfusion are considered to be helpful. An elevated oxygen delivery may be beneficial in some patients but the increase of oxygen delivery should be guided by the measurement of parameters assessing global and regional oxygenation. Forcing an increase in oxygen delivery by the use of very high dosages of catecholamines can be harmful. Vasopressors should be used for achieving an adequate perfusion pressure. For norepinephrine, no negative effects on regional perfusion have been demonstrated. Epinephrine and dopamine should be avoided because they seem to redistribute blood flow away from the splanchnic region. There are no convincing data yet to support the routine use of low dose dopamine or dopexamine in patients with sepsis. Neither low dose dopamine nor dopexamine has been proven to prevent renal failure in septic patients. Furthermore, there is evidence that low dose dopamine may reduce mucosal perfusion in the gut in some patients. There is some suggestion that dopexamine can improve splanchnic perfusion but since these effects remain somewhat controversial, there is no reason for a general recommendation for dopexamine in septic patients.
authors.affiliation: Department of Anaesthesiology and Intensive Care Medicine, Friedrich-Schiller-University, Jena, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Meier-Hellmann
authors.forename: S
authors.initials: S
authors.lastname: Sakka
authors.forename: K
authors.initials: K
authors.lastname: Reinhart
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use; D005440:Fluid Therapy; D006801:Humans; D018805:Sepsis / Q000188:drug therapy / Q000628:therapy*
chemical_list: D002317:Cardiovascular Agents